ABOUT GALILEO LIFE SCIENCES
Our origins
Galileo Life Sciences was founded by Charles-André Brouwers , a former Senior Partner and Managing Director at Boston Consulting Group, with the support of senior executives and leaders from across the pharmaceutical and biotechnology industry. The firm builds on that strategy consulting heritage and combines it with direct industry, operating, scientific, investing and transaction experience. Galileo Life Sciences was designed to combine the rigor and quality of leading global strategy firms with a leaner, more flexible model, led by senior professionals rather than large teams.
Built for life sciences
Important decisions in life sciences require a combination of scientific understanding, strategic judgment, operating experience and financial expertise. Our professionals bring backgrounds in strategy consulting, pharmaceutical and biotechnology leadership, scientific and medical training, investment banking and investing. This combination allows us to connect scientific and clinical considerations with commercial, operational and financial realities. We focus on the decisions that shape current and future growth, from portfolio and innovation strategy through product development, commercialization, business development and transactions.
Senior expertise, directly applied
Our model is deliberately lean and senior-led. Clients work directly with experienced professionals who remain closely involved throughout an engagement. We assemble teams around the specific needs of each situation rather than relying on large, standardized consulting structures. This gives clients the analytical depth associated with leading strategy firms, delivered with more direct senior involvement and greater flexibility.
From strategy through transaction
Our work spans four closely connected areas:
Strategy
Corporate and growth strategy, business planning, portfolio strategy and strategic decision support.
Innovation
R&D strategy, portfolio optimization, product and technology assessment, innovation scouting and external opportunity evaluation.
Commercial
Product strategy, go-to-market and launch planning, market assessment, pricing and market access, and strategies to accelerate growth and maximize product value.
Transactions
Asset scouting, business development and partnering, due diligence, mergers and acquisitions, strategic alternatives and private capital raising.
Because these capabilities sit within one firm, we can support a client from strategic assessment through implementation or transaction when appropriate, while also working on focused, standalone assignments.
Who we work with
Galileo Life Sciences advises pharmaceutical, biotechnology and medical technology companies ranging from emerging ventures to established global organizations. We also work with private equity firms, venture investors and other institutional investors evaluating life sciences companies, technologies and transactions. Our work spans both corporate and investor situations across the United States, Europe and other international markets.
Part of Galileo Global Group
Galileo Life Sciences is a member of Galileo Global Group, an independent advisory group bringing together expertise in strategy, finance and transactions. Where appropriate, Galileo Life Sciences works alongside Galileo Global Securities, a registered broker-dealer, to provide clients with transaction execution and capital-raising capabilities in addition to strategic advice. Galileo Life Sciences remains focused specifically on the life sciences industry and provides its strategy consulting and advisory services through dedicated life sciences professionals.
Galileo Life Sciences
Galileo Life Sciences LLC · Life sciences strategy consulting and transaction advisory · New York, United States · Serving pharmaceutical, biotechnology and medical technology companies and life sciences investors.